Current status of disease-modifying drugs in progressive rheumatoid arthritis

Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus.

Rheumatology (Oxford, England)·2007

Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?

Arthritis and rheumatism·2001

Spontaneous inflammatory disease in HLA-B27 transgenic mice does not require transporter of antigenic peptides.

Clinical immunology (Orlando, Fla.)·2001

HLA-B27 transgenic mice are susceptible to collagen-induced arthritis: type II collagen as a potential target in human disease.

Human immunology·2000

Lymphomas in patients with connective tissue disease. Comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate.

American journal of clinical pathology·2000

Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy.

Neurology·1999

Atacicept: First Approval.

Drugs·2026

Pivekimab Sunirine: First Approval.

Drugs·2026

Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer's Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes.

Drugs·2026

Vepdegestrant: First Approval.

Drugs·2026

Non-invasive Assessment and Therapeutic Targeting in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Overcoming the Dissonance Between Drug Development and Precision Medicine.

Drugs·2026

Baxdrostat: First Approval.

Drugs·2026

Exploring the therapeutic potential of Astragalin in Parkinson's disease: a network pharmacology approach.

Annals of medicine and surgery (2012)·2026

Knowledge, attitudes, and practices of Saudi physicians toward the use of SGLT-2 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus: a nationwide cross-sectional study.

Frontiers in endocrinology·2026

Exploring the use of digital and paper-based patient-held medication lists to improve medication adherence and health outcomes in polypharmacy: A scoping review.

Digital health·2026

Multiple blood pressure parameters and risk of incident diabetes in adults with elevated blood pressure: a cohort study with non-linear analyses.

Frontiers in endocrinology·2026

Reporting patterns of suicide- and self-injury-related events involving liraglutide, semaglutide, and tirzepatide: data from the European pharmacovigilance database.

Frontiers in pharmacology·2026

Effectiveness and renal safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis patients with chronic kidney disease stages 4-5: a real-world cohort study in China.

Frontiers in medicine·2026

Related Experiment Videos

Current status of disease-modifying drugs in progressive rheumatoid arthritis

Related Concept Videos

Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus.

Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?

Spontaneous inflammatory disease in HLA-B27 transgenic mice does not require transporter of antigenic peptides.

HLA-B27 transgenic mice are susceptible to collagen-induced arthritis: type II collagen as a potential target in human disease.

Lymphomas in patients with connective tissue disease. Comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate.

Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy.

Atacicept: First Approval.

Pivekimab Sunirine: First Approval.

Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer's Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes.

Vepdegestrant: First Approval.

Non-invasive Assessment and Therapeutic Targeting in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Overcoming the Dissonance Between Drug Development and Precision Medicine.

Baxdrostat: First Approval.

Exploring the therapeutic potential of Astragalin in Parkinson's disease: a network pharmacology approach.

Knowledge, attitudes, and practices of Saudi physicians toward the use of SGLT-2 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus: a nationwide cross-sectional study.

Exploring the use of digital and paper-based patient-held medication lists to improve medication adherence and health outcomes in polypharmacy: A scoping review.

Multiple blood pressure parameters and risk of incident diabetes in adults with elevated blood pressure: a cohort study with non-linear analyses.

Reporting patterns of suicide- and self-injury-related events involving liraglutide, semaglutide, and tirzepatide: data from the European pharmacovigilance database.

Effectiveness and renal safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis patients with chronic kidney disease stages 4-5: a real-world cohort study in China.

Related Experiment Videos

Current status of disease-modifying drugs in progressive rheumatoid arthritis

Related Concept Videos

Related Articles